PSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
Randomized clinical trials demonstrated the efficacy of psilocybin in reducing symptom severity in depression and MDMA in reducing PTSD symptomatology.
Furthermore, psychedelics often produce subjective effects (such as transcendence, mystical experiences, and a sense of oneness) that may be uniquely relevant to the existential distress experienced in PGD.
Read moreReference to an intrinsic healing mechanism or an ‘inner healer’ is commonplace amongst psychedelic users.
Read moreBeckley Psytech Ltd, the private, clinical-stage biopharmaceutical company dedicated to improving the lives of people living with neuropsychiatric disorders by developing effective and rapid-acting psychedelic medicines, today announced the publication of a new paper in The Journal of Psychopharmacology which demonstrates the safety, tolerability and rapid-acting subjective effects of BPL-003, Beckley Psytech’s novel, synthetic, intranasal benzoate salt formulation of 5-MeO-DMT (also known as mebufotenin).
Read moreIn a new study, researchers found that psychological flexibility, several facets of mindfulness, and values-congruent living significantly improved following psilocybin and were maintained through week 16.
Additionally, improvements in psychological flexibility and experiential acceptance were strongly associated with reductions in depression severity following psilocybin.
Keep reading for the full article at Nature.com
Read morePsychedelic music session playlists have been utilized consistently for modern psychedelic-assisted therapy clinical trials, and more recently researchers at Johns Hopkins University and Imperial College of London have specifically studied the effect of these music playlists on participants in trials.
Read moreBig news- a collaborative effort among scientists from the University of Texas at Arlington, Scottsdale Research Institute in Phoenix, Shimadzu Scientific Instruments in Maryland, and Millipore-Sigma in Round Rock, Texas, has led to the development of a new method for quantifying the potency of psilocybin and psilocin.
Read morePsychedelics can help dissolve the individual ego, an outcome sought in many spiritual traditions.
This dissolution fosters the understanding that one is not an isolated entity but part of a larger system.
Read moreThe government finally fast-tracked LSD as an anxiety treatment.
MindMed, the first publicly traded pharmaceutical company focused on psychedelics, said its drug has received a breakthrough designation from the FDA.
Read moreHere’s another look at HPPD, Hallucinogenic persistent perception disorder.
There are two types of HPPD: type 1 is characterised by brief "flashbacks", and type 2 sufferers experience chronic symptoms that can last months or a lifetime.
Read more